Xenetic Biosciences, Inc. (XBIO)
Last updated: 2026-11-15 15:16:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Xenetic Biosciences, Inc. (XBIO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.67, with a market capitalization of $3.89M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.58 to $4.94. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$3.89M | |
$1.78 | |
$1.89 | |
$1.66 | |
$1.66 | |
9.67K | |
75.51K | |
-- | |
$4.94 | |
$1.58 | |
-- | |
-- |
Xenetic Biosciences, Inc. (XBIO) Latest Closing Stock Price
Xenetic Biosciences, Inc. (XBIO) last closed at $1.67 as of 2026-11-14 00:31:00, down 5.96% ($0.11) from the previous close of $1.66.
During the latest regular trading session, XBIO traded between $1.66 and $1.89, with a volume of 9.67K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Xenetic Biosciences, Inc. (XBIO) 7-Day Stock Price Change
Over the past seven days, Xenetic Biosciences, Inc. (XBIO) moved from $1.87 to $1.67, representing a decline of 10.24% ($0.19).
The stock traded between $1.65 and $1.99 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 12.22 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
XBIO 52-Week Price Position
Position in Range: 2.8%
XBIO is currently trading at $1.67, placing it 2.8% of the way from its 52-week low of $1.58 to its 52-week high of $4.94. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Xenetic Biosciences, Inc. (XBIO)?
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.
Xenetic Biosciences, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
XBIO News
Latest news related to Xenetic Biosciences, Inc. and XBIO stock.
- Read Full Article
- Read Full Article
Xenetic Biosciences Says All-Stock Share Exchange With Santersus Expected To Close In Q1 2027; Combined Company To Trade As Santersus Bio Under SNTS
- Read Full Article
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Addex Therapeutics (NASDAQ:ADXN) stock rose 74.0% to $5.03 during Thursday's pre-market session. ZeroStack (NASDAQ:ZSTK) stock increased by 11.56% to $2.99. The market value of their outstanding shares is
Ways to Trade XBIO at MEXC
How to Buy Xenetic Biosciences, Inc. (XBIO) Stock on MEXC
Eligible investors can buy real shares of Xenetic Biosciences, Inc. (XBIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Xenetic Biosciences, Inc. (XBIO) stock price today?
2.Is XBIO stock going up or down today?
3.What is XBIO pre-market price?
4.What is XBIO after-hours price?
5.Is XBIO stock trading now?
6.Where does XBIO sit relative to its 52-week high and low?
7.What sector is Xenetic Biosciences, Inc. in?
8.What is Xenetic Biosciences, Inc.'s market capitalization and where is it listed?
9.How is XBIO valued in terms of P/E ratio and EPS?
10.Does Xenetic Biosciences, Inc. pay a dividend?
Explore More US Stocks
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to XBIO, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
XBIO Stock Calculator
Estimate the value between XBIO shares and USD.
XBIO Shares to USD
1.00 XBIO shares = 1.674 USD
Calculations are estimates based on the latest available price and are for reference only.


